Navigation Links
NeuroQuest Close to Validation Trial for Biomarker Platform in Diagnosis of Alzheimer's

TEL AVIV, Israel, December 10, 2012 /PRNewswire/ --

NeuroQuest, a company of the Trendlines Group's Misgav Venture Accelerator is moving quickly towards an important validation trial for novel blood-based immune biomarkers for the diagnosis of Alzheimer's disease. The company's biomarker platform for neurodegenerative diseases is based on the research of Prof. Michal Schwartz, Chair of Neuroimmunology at the Weizmann Institute of Science who pioneered the concept of Protective AutoImmunity. The trial is a follow-up to the preliminary human trial performed at Sheba, Rambam, and Abarbanel Medical Centers in Israel and Methodist Neurological Institute in Houston, Texas which demonstrated up to 85% diagnostic accuracy and specificity in AD and ALS patients in mild to moderate stages versus healthy controls. The success of the validation trial would present a new approach for a simple, inexpensive, and early diagnosis of Alzheimer's disease. Successful results may lead to new therapeutic targets for this disease, opening new directions to an industry searching for novel approaches to combat AD, given the recent failures of several Phase III trials for therapeutics targeting Beta-Amyloid reduction.

Dr. Jacobo Mintzer, Co-Director of Alzheimer's Research & Clinical Programs of the Medical University of South Carolina, has joined the company as its new VP of Clinical affairs to leverage his experience in over 200 Alzheimer's-related clinical trials. NeuroQuest has also announced a new partnership with the Harvard Clinical Research Institute and their Senior Director of Clinical Program Management, Dr. Jennifer Buell. Together the teams are gearing up for a 150-200 patients clinical trial at MUSC, Harvard, and other medical centers to validate the company's novel immune-based biomarkers for Alzheimer's Disease.

The company has confirmed financing totaling $500,000 led by InterTech Group, headed by Jonathan Zucker, and the Maryland/Israel Trendlines Fund. The company is also in serious discussions with the South Carolina Research Authority (SCRA) about a grant to support opening a US development center in Charleston, SC as the base of its clinical and regulatory work. Many of these developments were put into motion following a 2011 American Israel Chamber of Commerce - South East's (AICC-SE) delegation from South Carolina headed by Tom Glaser. Glaser's group, returned to Israel and Misgav again this week to celebrate and investigate additional opportunities for collaboration and investment.

Efrat Kaduri
Ofir Shpigel Media and Public Relations

SOURCE NeuroQuest
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Wright Therapy Products, Inc. Closes $3 million Financing Round
2. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
3. Edison Pharmaceuticals Closes $20M Series F Financing
4. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
5. DenTech China 2012 Closed with Success
6. Agnitio Sets Up Asia HQ in Shanghai and is the First to Bring the Combined Closed Loops of Marketing and E-Learning to the Pharmaceutical Industry
7. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
8. Novelos Therapeutics Closes $2 Million Private Placement
9. ClosedWon Launches QuickQuote at Dreamforce 2012 on Salesforce.coms AppExchange, the Worlds Most Popular Cloud Marketplace for Social Apps for Business
10. RxAnte Closes Series A Financing
11. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
Post Your Comments:
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... 2016 Research and Markets ... Electronics 2015-2025: Applications, Technologies, Forecasts" report to ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, Composite ... Structural electronics involves electronic and/or electrical components and ... dumb structures such as vehicle bodies or conformally ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):